AssetMark Inc
CL icon

AssetMark Inc’s Colgate-Palmolive CL Stock Holding History

AssetMark Inc’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93M Buy
22,602
+3,519
+18% +$314K ﹤0.01% 897
2025
Q4 		$1.51M Sell
19,083
-4,125
-18% -$323K ﹤0.01% 927
2025
Q3 		$1.86M Buy
23,208
+2,091
+10% +$178K ﹤0.01% 829
2025
Q2 		$1.92M Buy
21,117
+4,292
+26% +$392K ﹤0.01% 778
2025
Q1 		$1.58M Buy
16,825
+545
+3% +$48.8K ﹤0.01% 777
2024
Q4 		$1.48M Buy
16,280
+12,160
+295% +$1.16M ﹤0.01% 774
2024
Q3 		$428K Sell
4,120
-474
-10% -$48.3K ﹤0.01% 911
2024
Q2 		$446K Sell
4,594
-305
-6% -$28.1K ﹤0.01% 889
2024
Q1 		$441K Buy
4,899
+503
+11% +$42.6K ﹤0.01% 846
2023
Q4 		$350K Sell
4,396
-3,916
-47% -$294K ﹤0.01% 835
2023
Q3 		$591K Buy
8,312
+386
+5% +$28.9K ﹤0.01% 724
2023
Q2 		$611K Sell
7,926
-1,306
-14% -$101K ﹤0.01% 691
2023
Q1 		$694K Buy
9,232
+413
+5% +$30.7K ﹤0.01% 665
2022
Q4 		$695K Buy
8,819
+5
+0.1% +$375 ﹤0.01% 658
2022
Q3 		$619K Buy
8,814
+249
+3% +$19.5K ﹤0.01% 620
2022
Q2 		$686K Sell
8,565
-8,523
-50% -$666K ﹤0.01% 578
2022
Q1 		$1.3M Buy
17,088
+5,630
+49% +$446K 0.01% 417
2021
Q4 		$978K Sell
11,458
-44,444
-80% -$3.47M ﹤0.01% 411
2021
Q3 		$4.22M Buy
55,902
+47,723
+583% +$3.79M 0.02% 266
2021
Q2 		$665K Buy
8,179
+571
+8% +$46.7K ﹤0.01% 425
2021
Q1 		$600K Buy
7,608
+878
+13% +$68.8K ﹤0.01% 424
2020
Q4 		$575K Buy
6,730
+169
+3% +$14K ﹤0.01% 419
2020
Q3 		$506K Buy
6,561
+852
+15% +$65K ﹤0.01% 403
2020
Q2 		$418K Sell
5,709
-11,770
-67% -$836K ﹤0.01% 401
2020
Q1 		$1.16M Buy
17,479
+12,089
+224% +$853K 0.01% 303
2019
Q4 		$371K Buy
5,390
+1,074
+25% +$73.2K ﹤0.01% 441
2019
Q3 		$317K Buy
4,316
+1,983
+85% +$144K ﹤0.01% 420
2019
Q2 		$167K Buy
2,333
+618
+36% +$43.9K ﹤0.01% 501
2019
Q1 		$118K Sell
1,715
-716
-29% -$46.2K ﹤0.01% 542
2018
Q4 		$145K Sell
2,431
-253
-9% -$15.8K ﹤0.01% 489
2018
Q3 		$180K Sell
2,684
-917
-25% -$61.1K ﹤0.01% 470
2018
Q2 		$233K Buy
3,601
+1
+0% +$65 ﹤0.01% 433
2018
Q1 		$258K Sell
3,600
-644
-15% -$46.3K ﹤0.01% 410
2017
Q4 		$320K Sell
4,244
-279
-6% -$20.4K ﹤0.01% 418
2017
Q3 		$329K Buy
4,523
+109
+2% +$7.86K ﹤0.01% 393
2017
Q2 		$327K Sell
4,414
-131
-3% -$9.73K ﹤0.01% 376
2017
Q1 		$333K Buy
4,545
+75
+2% +$5.25K ﹤0.01% 369
2016
Q4 		$293K Sell
4,470
-417
-9% -$28.6K ﹤0.01% 370
2016
Q3 		$362K Sell
4,887
-86
-2% -$6.36K 0.01% 334
2016
Q2 		$364K Sell
4,973
-197
-4% -$14K 0.01% 337
2016
Q1 		$365K Buy
5,170
+161
+3% +$10.7K 0.01% 332
2015
Q4 		$334K Buy
5,009
+4,994
+33,293% +$332K 0.01% 380
2015
Q3 		$1K Buy
+15
New +$980 ﹤0.01% 658
2014
Q3 		– Sell
-8
Closed -$1K – 460
2014
Q2 		$1K Sell
8
-9,068
-100% -$608K ﹤0.01% 466
2014
Q1 		$589K Sell
9,076
-305
-3% -$19.2K 0.01% 301
2013
Q4 		$612K Sell
9,381
-1,350
-13% -$86.4K 0.01% 313
2013
Q3 		$636K Buy
+10,731
New +$636K 0.02% 305

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AssetMark Inc's CL Position: Q1 2026 in Review

AssetMark Inc increased its Colgate-Palmolive (CL) stake by 18% in Q1 2026, buying an estimated $314K and bringing the position to 22,602 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #897.

AssetMark Inc first reported a position in CL in Q3 2013 and has held it in 47 quarters since. The position peaked at $4.22M in Q3 2021. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • AssetMark Inc held 22,602 shares of Colgate-Palmolive worth $1.93M as of Q1 2026.
  • AssetMark Inc bought 3,519 Colgate-Palmolive shares in Q1 2026, an estimated $314K.
  • Colgate-Palmolive made up ﹤0.01% of AssetMark Inc's portfolio in Q1 2026, its #897 holding.
  • AssetMark Inc first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 47 quarters since.
  • AssetMark Inc's Colgate-Palmolive position peaked at $4.22M in Q3 2021.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.